Pharma Focus Positioned as an enterprise-grade real-time editor for scientific documents, doDOC targets pharmaceutical and biotechnology teams, backed by the Envision Pharma Group. With access to Envision’s network, including many top pharma companies, there is a strong co-sell and cross-sell opportunity across R&D, regulatory, and medical writing teams. The platform’s granular permissions, full action traceability, automation, and fast collaboration can help cut document cycles, with claims of up to 70% faster writing and review.

Regulatory Readiness doDOC’s granular permissions and complete activity traceability address the needs of regulated pharma workflows, delivering robust audit trails for submissions, approvals, and regulatory correspondence. This makes it attractive to compliance and validation teams seeking to reduce risk and accelerate inspections, by ensuring controlled access and traceable changes across documents.

Integration Potential The product emphasizes flexible integrations that build on existing systems, positioning it as a central workflow hub rather than a replacement for current investments. This creates a compelling path for IT and operations teams to adopt doDOC across ELN, LIMS, QMS, and other clinical and quality workflows, while enabling automation to improve data consistency.

Strategic Backing Acquired by Envision Pharma Group in 2021, doDOC benefits from a pharma-focused parent with an established enterprise sales engine and a client base spanning numerous leading pharma companies. This affiliation offers a clear path to scaling within Envision’s network and leveraging its global footprint to win large enterprise deals.

Speed Advantage Speed and differentiation: doDOC markets itself as the only real-time collaborative editor for scientific documents, delivering faster drafting and review with granular permissions and action automation. This positions it well for distributed R&D and medical writing teams in pharma/biotech, making it suitable for pilots or initial deployments within top accounts and Envision’s client base.